Polymer Cell Surface Coating Enhances Mesenchymal Stem Cell Retention and Cardiac Protection

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Research

Background:

• Mesenchymal stem cell (MSC) therapy shows promise for myocardial infarction (MI) recovery.
• Clinical translation is hindered by low cell retention and high donor cell requirements.
• Existing hydrogel scaffolds may impede MSC function and environmental interaction.

Purpose of the Study:

• To investigate the cardiac protective effects of gelMA-coated, hypoxia-preconditioned MSCs (gelMA-MSCs) in a murine MI model.
• To assess the impact of gelMA coating on MSC engraftment, cardiac function, and repair.
• To evaluate the immunomodulatory capacity of gelMA-MSCs post-MI.

Main Methods:

• Developed a nanoscale gelMA cell-coating technique for MSCs.
• Administered gelMA-MSCs via direct injection into a murine MI model.
• Quantified myocardial engraftment, cardiac function (echocardiography), scar size, and angiogenesis at 7 days post-MI.

Main Results:

• GelMA-MSC injection resulted in significantly higher myocardial engraftment compared to uncoated MSCs.
• Enhanced cardioprotection was observed, including improved cardiac function, reduced scar size, and increased angiogenesis.
• Improved MSC retention correlated with greater cardiac immunomodulatory function.

Conclusions:

• GelMA-MSCs demonstrate efficacy in treating cardiac injury post-MI.
• The gelMA coating technique enhances MSC engraftment and therapeutic benefits.
• This approach holds potential to reduce donor MSC requirements in clinical applications.